Author: ODWAdmin

Namocell, Takara Bio USA and HepaTx collaborate on single cell genomics analysis for cell therapy to treat late-stage liver diseases

Mountain View, Calif., (February 20, 2020) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms, announced today that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells (iHeps) developed from adipose tissue-derived stromal […]

Namocell Appoints VP of Engineering

Mountain View, Calif., (October 30, 2019) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms to advance single cell research and development, announced that Dr. Bob Cao has joined the company as VP of Engineering. Bob brings over 20 years of engineering and innovation leadership experience. He spent 12 years at […]

Namocell Names New VP of Marketing and Business Development

Mountain View, Calif., (September 9, 2019) – Namocell Inc., a leading provider of single cell sorting and dispensing platforms, today announced that Abe Couse has joined the company’s management team as VP of Marketing and Business Development. Abe brings over 20 years of life science commercial leadership experience in marketing, sales, business and product development, […]

Namocell Enters the Netherlands, Belgium and Luxembourg Market with BIOKÉ Distributorship

Mountain View, Calif., (July 25, 2018) – Namocell Inc., a leading provider of high-performance single cell dispensing and sorting platforms for life science applications, today announced it has entered into a distribution agreement with BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), to distribute Namocell’s Namo Single Cell Dispenser in the Netherlands, […]

Namocell Expands to Korea with MDxK Distribution Deal

Mountain View, Calif., (July 10, 2018) – Namocell recently announced that it has signed two separate distribution deals for its Namo Single Cell Dispenser tool with MDxK in South Korea and with Bioké in the Netherlands, Belgium, and Luxembourg. The firm’s microfluidic-based cell platform dispenses single cells into a 96-well plate in less than a […]

Namocell Signs Distribution Deal with Tomy Digital in Japan

Mountain View, Calif., (June 20, 2018)  –  Namocell announced today that it has signed an agreement with Tomy Digital Biology to distribute Namocell’s Namo Single Cell Dispenser in Japan. Financial details of the agreement were not disclosed. Namocell’s microfluidic-based cell platforms dispense single cells into a 96-well plate in less than a minute, the company […]

Namocell and MGH Collaborate on Circulating Tumor Cell Research

Mountain View, Calif., (December 16, 2016)  –  Namocell, a developer of microfluidic-based single-cell sorting and capturing platforms, has announced a collaboration with researchers at Massachusetts General Hospital to research circulating tumor cells. Namocell will work with the MGH team to isolate CTCs and CTC clusters from cancer patient blood samples using its Namo Single Cell […]

Namocell and Stanford Partner to Test Single Cell Sorting Technology in Cancer Cells

Mountain View, Calif., (October 14, 2016)  – Silicon Valley-based startup Namocell announced this week that it has formed a partnership with Stanford University to test its microfluidics-based single cell sorting system with circulating tumor cells (CTCs). The Namo Single Cell Dispenser is a benchtop instrument designed to perform single cell sorting and dispensing in one […]

Stanford University and Namocell Collaborate to Study Circulating Tumor Cells (CTCs)

Mountain View, Calif., (October 13, 2016)  – Namocell announced today a collaboration with Stanford University School of Medicine on circulating tumor cell (CTC) research. The collaboration focuses around work being done in the laboratory of Dr. Stefanie Jeffrey, John and Marva Warnock Professor and Chief of Surgical Oncology Research, Stanford University. Professor Jeffrey’s lab will […]